1. Abdel Ghani, E. M., S. Weis, I. Walev, M. Kehoe, S. Bhakdi, M.
Palmer. 1999. Streptolysin O: inhibition of the conformational change during membrane binding of the monomer prevents oligomerization and pore formation. Biochemistry. 38:15204-11.
2. Alcantara, R. B., L. C. Preheim, M. J. Gentry-Nielsen. 2001. Pneu-molysin-induced complement depletion during experimental pneumo-coccal bacteremia. Infect. Immun. 69:3569-75.
3. Alexander J. E. , R. A. Lock, C. C. Peeters, J. T. Poolman, P. W.
Andrew, T. J. Mitchell, D. Hansman, J. C. Paton. 1994. Immuniza-tion of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumo-niae. Infect. Immun. 62:5683-8.
4. Baba, H., I. Kawamura, C. Kohda, T. Nomura, Y. Ito, T. Kimoto, I.
Watanabe, S. Ichiyama, M. Mitsuyama. 2002. Induction of gamma in-terferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect. Immun. 70:107-13.
5. Baquero, F., J. Martinez-Beltran, and E. Lozan. 1991. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe.
J. Antimicrob. Chemother. 28:31-8.
6. Beall, B., R. R. Facklam, D. M. Jackson, H. H. Starling. 1998. Rapid screening for penicillin susceptibility of systemic pneumococcal iso-lates by restriction enzyme profiles of the pbp2B gene. J. Clin. Micro-biol. 36:2359-2362.
7. Belperio, J. A., M. P. Keane, M. D. Burdick, V. Londhe, Y. Y. Xue, K. Li, R. J. Phillips, R. M. Strieter. 2002. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung in-jury. J. Clin. Invest. 110:1703-16.
8. Benton, K. A., J. L. VanCott, D. E. Briles. 1998. Role of tumor necro-sis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae. Infect. Immun.
66:839-42.
9. Bergeron, Y., N. Ouellet, A. M. Deslauriers, M. Simard, M. Olivier, M. G. Bergeron. 1998. Cytokine kinetics and other host factors in re-sponse to pneumococcal pulmonary infection in mice. Infect. Immun.
66:912-22.
10. Bhakdi, S., J. Tranum-Jensen, J., A. Sziegoleit. 1985. Mechanism of membrane damage by streptolysin-O. Infect. Immun. 47:52-60.
11. Blue, C. E., G. K. Paterson, A. R. Kerr, M. Berge, J. P. Claverys, T.
J. Mitchell. 2003. ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect. Immun. 71:4925-35.
12. Bogaert D., R. De Groot, P. W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. 2004.
Lancet Infect. Dis. 4:144-54.
13. Bonev, B. B., R. J. Gilbert, P. W. Andrew, O. Byron, A. Watts. 2001.
Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneumolysin. J. Biol. Chem. 276:5714-9.
14. Braun, J. S., R. Novak, G. Gao, P. J. Murray, J. L. Shenep. 1999.
Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect. Immun. 67:3750-6.
15. Briles, D. E., J. Yother, L. S. McDaniel. 1988. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev.
Infect. Dis. 2:372-4.
16. Briles, D. E., S. K. Hollingshead, E. Swiatlo, A. Brooks-Walter, A.
Zyalai, A. Virolainen, L. S. McDaniel, K. A. Benton, P. White, K.
Preller, A. Hermansson, P. C. Aerts, H. Van Dijk, and M. J. Crain.
1997. PspA and PspC: their potential for use as pneumococcal vac-cines. Microb. Drug Resist. 3:401-8.
17. Briles, D. E., S. K. Hollingshead, J. C. Paton, E. W. Ades, L. Novak, F. W. van Ginkel, W. H. Jr. Benjamin. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188:339-48.
18. Brown, J. S., T. Hussell , S. M. Gilliland, D. W. Holden, J. C. Paton, M. R. Ehrenstein, M. J. Walport, M. Botto. 2002. The classical path-way is the dominant complement pathpath-way required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci.
U.S.A. 99:16969-74.
19. Camara, M, G. J. Boulnois, P. W. Andrew, T. J. Mitchell. 1994. A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect. Immun. 62:3688-95.
20. Chandler, L. J., B.S. Reisner, G. L. Woods, A. K. Jafri. 2000. Com-parison of four methods for identifying Streptococcus pneumoniae. Di-agn. Microbiol. Infect. Dis. 37:285-7.
21. Choi, Y., L. F. Chuang, K. M. Lam, H. F. Kung, J. M. Wang, B. I.
Osburn, R. Y. Chuang. 1999. Inhibition of chemokine-induced chemo-taxis of monkey leucocytes by mu-opioid receptor agonists. In Vivo.
13:389-96.
22. Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, F.
Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689-92.
23. Cockeran, R., A. J. Theron, H. C. Steel, N. M. Matlola, T. J.
Mitchell, C. Feldman, R. Anderson. 2001. Proinflammatory interac-tion of pneumolysin with human neutrophils. J. Infect. Dis. 183:604-11.
24. Cockeran, R., C. Durandt, C. Feldman, T. J. Mitchell, R. Anderson.
2002. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 186:562-5.
25. Cockeran, R., R. Anderson, C. Feldman. 2002. The role of pneumo-lysin in the pathogenesis of Streptococcus pneumoniae infection. Curr.
Opin. Infect. Dis. 15:235-9.
26. Crain, M. J., W. D. 2nd. Waltman, J. S. Turner, J. Yother, D. F. Talk-ington, L. S. McDaniel, B. M. Gray, D. E. Briles. 1990. Pneumococ-cal surface protein A (PspA) is serologiPneumococ-cally highly variable and is ex-pressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect. Immun. 58:3293-9.
27. Cundell, D. R., N. P. Gerard, C. Gerard, I. Idanpaan-Heikkila, E. I.
Toumanen. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377:435-8.
28. Dintilhac, A., G. Alloing, C. Granadel, and J. P. Claverys. 1997.
Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inac-tivation of putative ABC metal permaeses. Mol. Microbiol. 25:727-739.
29. Doerschuk, C. M., R. K. Winn, H. O. Coxson, J. M. Harlan. 1990.
CD18-dependent and –independent mechanisms of neutrophil emigra-tion in the pulmonary and systemic microcirculaemigra-tion of rabbits. J. Im-munol. 144:2327-33
30. Driscoll, K. E., D. G. Hassenbein, J. Carter, J. Poynter, T. N. As-quith, R. A. Grant, J. Whitten, M. P. Purdon, R. Takigiku. 1993.
Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after min-eral dust exposure. Am. J. Respir. Cell. Mol. Biol. 8:311-8.
31. Duran-Reynals, F. 1933. Studies on a certain spreading factor exist-ing in bacteria and its significance for bacterial invasiveness. J. Exp.
Med. 58:161-81.
32. Facklam, R. 2002. What happened to the Streptococci: Overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 15: 613–
30. Review.
33. Feldman C., R. Anderson, R. Cockeran, T. Mitchell, P. Cole, R.
Wilson. The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro. 2002. Respir.
Med. 96:580-5.
34. Fernebro, J., I. Andersson, J. Sublett, E. Morfeldt, R. Novak, E.
Tuomanen, S. Normark, B. H. Normark. 2004. Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and an-tibiotic-induced lysis and contributes to antibiotic tolerance. J. Infect.
Dis. 189: 328-38.
35. Geissmann, F., S. Jung, D. R. Littman. 2003. Blood monocytes con-sist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
36. Gibson, R. L., V. Nizet, C. E. Rubens. 1999. Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells.
Pediatr. Res. 45:626-34.
37. Gilbert, R. J., J. L. Jimenez, S. Chen, I. J. Tickle, J. Rossjohn, M.
Parker, P. W. Andrew, H. R. Saibil. 1999. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell. 97:647-55.
38. Hogg, J. C., C. M. Doerschuk. 1995. Leukocyte traffic in the lung.
Annu. Rev. Physiol. 57:97-114.
39. Huo Z, O. Spencer, J. Miles, J. Johnson, R. Holliman, J. Sheldon, P. Riches. 2004. Antibody response to pneumolysin and to pneumo-coccal capsular polysaccharide in healthy individuals and Streptococ-cus pneumoniae infected patients. Vaccine. 22:1157-61.
40. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Ta-keda, K. TaTa-keda, S. Akira. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-52.
41. Houldsworth, S., P. W. Andrew, T. J. Mitchell. 1994. Pneumolysin stimulates production of tumour necrosis factor and interleukin 1ß by human mononuclear phagocytes. Infect. Immun. 62:1501-3.
42. Jedrzejas, M. J. 2001. Pneumococcal virulence factors: structure and function. Microbiol. Mol. Rev. 65:187-207.
43. Johnson, M. K., D. Boese-Marrazzo, W. A. Jr. Pierce. 1981. Effects of pneumolysin on human polymorphonuclear leukocytes and plate-lets. Infect. Immun. 34:171-6.
44. Jounblat, R., A. Kadioglu, T.J. Mitchell, P.W. Andrew. 2003. Pneu-mococcal behaviour and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating ac-tivities of pneumolysin. Infect. Immun. 71:1813-9.
45. Kadioglu, A., N. A. Gingles, K. Grattan, A. Kerr, T. J. Mitchell, P.
W. Andrew. 2000. Host cellular immune response to pneumococcal lung infection in mice. Inf. Immun. 68:492-501.
46. Kadioglu, A., S. Taylor, F. Iannelli, G. Pozzi, T. J. Mitchell, P. W.
Andrew. 2002. Upper and lower respiratory tract infection by Strepto-coccus pneumoniae is affected by pneumolysin deficiency and differ-ences in capsule type. Infect. Immun. 70: 2886-90.
47. Kelly, R., and D. Greiff. 1970. Toxicity of pneumococcal neuramini-dase. Infect. Immun. 2: 115-7.
48. Kelly, T., J. P. Dillard, and J. E. Yother. 1994. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.
Infect. Immun. 62:1813-19.
49. Klugman, K. P., S. A. Madhi, R. E. Huebner, R. Kohberger, N.
Mbelle, N. Pierce;Vaccine Trialists Group. 2003. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349:1341-8.
50. Koay, M. A., X. Gao, M. K. Washington, K. S. Parman, R. T.
Sadikot, T. S. Blackwell, J. W. Christman. 2002. Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am. J. Respir. Cell Mol. Biol. 26:572-8.
51. Krivan, H. C., D. D. Roberts, and V. Ginsburg. 1988. Many pulmo-nary pathogenic bacteria bind specifically to the carbohydrate se-quence GalNAc beta 1-4Gal found in some glycolipids. Proc. Natl.
Acad. Sci. U. S. A. 85:6157-61.
52. Lock, R. A., D. Hansman, J. C. Paton. 1992. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against in-fection by Streptococcus pneumoniae. Microb. Pathog. 12:137-43.
53. Lopez, R., J. L. Garcia, E. Garcia, C. Ronda, P. Garcia. 1992. Struc-tural analysis and biological significance of the cell wall lytic enzymes of Streptococcus pneumonite and its bacteriophage. F. E. M. S. Micro-biol. Lett. 79:439-47.
54. Mack, M., J. Cihak, C. Simonis, B. Luckow, A. E. Proudfoot, J. Pla-chy, H. Bruhl, M. Frink, H. J. Anders, V. Vielhauer, J. Pfirstinger, M. Stangassinger, D. Schlondorff. 2001. Expression and characteri-zation of the chemokine receptors CCR2 and CCR5 in mice. J. Immu-nol. 166:4697-704.
55. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R. Wessels, D. T.
Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers confers resistance to pneumococcal infection. Infect. Immun.
100:1966-71.
56. Marriott, H. M., F. Ali, R. C. Read, T. J. Mitchell, M. K. Whyte, D. H.
Dockrell. 2004. Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. F. A. S. E. B.
J. May 7.
57. Maus, U. A., J. Huwe, L. Ermert, W. Seeger, J. Lohmeyer. 2002.
Molecular pathways of monocyte emigration into the alveolar air space of intact mice. Am. J. Respir. Crit. Care Med. 164:1-7.
58. Maus, U. A. , J. Huwe, R. Maus, W. Seeger, J. Lohmeyer. 2001. Al-veolar JE/MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx and vascular leakage in mice. Am. J. Respir. Crit. Care Med. 164:406-411.
59. Maus, U. A., K. von Grote, W. A. Kuziel, M. Mack, E. J. Miller, J.
Cihak, M. Stangassinger, R. Maus, D. Schlöndorff, W. Seeger, J.
Lohmeyer. 2002. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am. J. Respir.
Crit. Care Med. 166:268-73.
60. Maus, U. A., K. Waelsch, W. A. Kuziel, T. Delbeck, M. Mack, T. S.
Blackwell, J. W. Christman, D. Schlöndorff, W. Seeger, J. Loh-meyer. 2003. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J.
Immunol. 170:3273-78.
61. Maus, U. A., M. A. Koay, T. Delbeck, M. Mack, M. Ermert, L. Er-mert, T. S. Blackwell, J. W. Christman, D. Schlöndorff, W. Seeger, J. Lohmeyer. 2002. Role of resident alveolar macrophages in leuko-cyte traffic into the alveolar air space of intact mice. Am. J. Physiol.
Lung Cell. Mol. Physiol. 282:L1245-L1252.
62. Maus, U. A., S. Henning, H. Wenschuh, K. Mayer, W. Seeger, J.
Lohmeyer. 2002. Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow. Am. J. Physiol.
Heart Circ. Physiol. 283:H2584-91.
63. Maus, U. A., S. Wellmann, C. Hampl, W. A. Kuziel, M. Srivastava, M. Mack, M. B. Everhart, T. S. Blackwell, J. W. Christman, D.
Schlöndorff, R. M. Bohle, W. Seeger, J. Lohmeyer. 2004. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels. Am. J. Physiol. Lung Cell. Mol. Physiol.
288:350-8.
64. Metlay, J. P., M. D. Witmer-Pack, R. Agger, M. T. Crowley, D. Law-less, R. M. Steinmann. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster mono-clonal antibodies. J. Exp. Med. 171:1753-71.
65. Murdoch, D. A. 1998. Gram-positiv anaerobic cocci. Clin. Microbiol.
Rev. 11:81-120.
66. Nabors, G. S., P. A. Braun, D. J. Herrmann, M. L. Heise, D. J. Pyle, S. Gravenstein, M. Schilling, L. M. Ferguson, S. K. Hollingshead, D. E. Briles, R. S. Becker. 2000. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18:1743-54.
67. Orihuela, C. J, G. Gao, K. P. Francio, J. Yu, E. I. Tuomanen. 2004.
Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190:1661-9.
68. Ortqvist, A., I. Jonsson, M. Kalin, and A. Krook. 1989. Comparison of three methods for detection of pneumococcal antigen in sputum of patients with community-acquired pneumonia. Eur. J. Clin. Microbiol.
Infect. Dis. 8:956-961.
69. Palmer, M., I. Vulicevic, P. Saweljew, A. Valeva, M. Kehoe, S. Bha-kdi. 1998. Streptolysin O: a proposed model of allosteric interaction between a pore-forming protein and its target lipid bilayer. Biochemis-try 37:2378-83.
70. Paton, J. C. 1996. The contribution of pneumolysin to the pathogenic-ity of Streptococcus pneumoniae. Trends in Microbiol. 4:103-6.
71. Paton, J. C. 1998. Novel pneumococcal surface proteins: role in viru-lence and vaccine potential. Trends in Microbiol. 6:85-7.
72. Paton, J. C., R. A. Lock, C. J. Lee, J. P. Li, A. M. Berry, T. J.
Mitchell, P. W. Andrew, D. Hansman, G. J. Boulnois. 1991. Purifica-tion and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysac-charide. Infect. Immun. 59:2297-304.
73. Ponnuraj, K., and M. J. Jedrzejas. 2000. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hya-luronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J. Mol. Biol. 299:885-95.
74. Rayner, C. F, A. D. Jackson , A. Rutman, A. Dewar, T. J. Mitchell, P. W. Andrew, P. J. Cole, R. Wilson. 1995. Interaction of pneumo-lysin-sufficient and –deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect. Immun. 63: 442-7.
75. Ren B., A. J. Szalai, S. K. Hollingshead, D. E. Briles. 2004. Effects of PspA and antibodies to PspA on activation and deposition of com-plement on the pneumococcal surface. Infect. Immun. 72:114-22.
76. Ridger, V. C., B. E. Wagner, W. A. H. Wallace, P. G. Hellewell.
2001. Differential effects of CD18, CD29, CD49 integrin subunit inhibi-tion on neutrophil migrainhibi-tion in pulmonary inflammainhibi-tion. J. Immunol.
166:3484-90.
77. Rijneveld, A. W., G. P. van den Dobbelsteen, S. Florquin, T. J.
Standiford, P. Speelman, L. van Alphen, T. van der Poll. 2002.
Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis.
185:123-6.
78. Robbins, J. B., R. Austrian, C. J. Lee, S. C. Rastogi, G.Schiffman, J. Henrichsen, P. H. Makela, C. V. Broome, R. R. Facklam, R. H.
Tiesjema, et al. 1983. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with em-phasis on the cross-reactive types within groups. J. Infect. Dis.
148:1136-59.
79. Rosenow, C., P. Ryan, J. N. Weiser, S. Johnson, P. Fontan, A.
Ortqvist, H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococ-cus pneumoniae. Mol. Microbiol. 25:819-29.
80. Rosseau, S., J. Selhorst, K. Wiechmann, K. Leissner, U. Maus, K.
Mayer, F. Grimminger, W. Seeger, J. Lohmeyer. 2000. Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines. J. Immunol. 164:427-35.
81. Rossjohn, J., R. J. Gilbert, D. Crane, P. J. Morgan, T. J. Mitchell, A.
J. Rowe, P. W: Andrew; J. C. Paton, R. K. Tweten, M. W. Parker.
1998. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J. Mol. Biol. 284:449-61.
82. Rubins, J. B., D. Charboneau, C. Fasching, A. M. Berry, F. C. Pa-ton, J. E. Alexander, P. W. Adrew, T. J. Mitchell, E. N. Janoff. 1996.
Distinct roles for pneumolysin’s cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am. J. Respir. Crit.
Care Med. 153:1339-46.
83. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W.
Adrew, E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Invest.
95:142-50.
84. Rubins, J. B., P. G. Duane, D. Charboneau, E. N. Janoff. 1992. Tox-icity of pneumolysin to pulmonary endothelial cells in vitro. Infect. Im-mun. 60:1740-6.
85. Rubins, J. B., P. G. Duane, D. Clawson, D. Charboneau, A. Young, D. E. Niewoehner. 1993. Toxicity of pneumolysin to pulmonary alveo-lar epithelial cells. Infect. Immun. 61:1352-8.
86. Schleifer, K. H., R. Kilpper-Balz. 1987. Molecular and chemotax-onomic approaches to the classification of streptococci, enterococci and lactococci: a review. Syst. Appl. Microbiol. 10:1-19.
87. Schuchat, A.1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
88. Smith, J. D., N. J. Cortes, G. S. Evans, R. C. Read, A. Finn. 1998.
Induction of beta2 integrin-dependent neutrophil adhesion to human alveolar epithelial cells by type 1 Streptococcus pneumoniae and de-rived soluble factors. J. Infect. Dis. 177:977-85.
89. Simpson, S. Q., R. Singh, D. E. Bice. 1994. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages. Am. J. Respir. Cell.
Mol. Biol. 10:284-9.
90. Sorensen, U. B. S. 1993. Typing of pneumococcal by using 12 pooled antisera. J. Clin. Microbiol. 31:2097-100.
91. Steinfort, C., R. Wilson, T. Mitchell, C. Feldman, A. Rutman, H.
Todd, D. Sykes, J. Walker, K. Saunders, P. W. Andrew, G. J. Boul-nois, P. J. Cole. 1989. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect. Immun. 57:2006-13.
92. Toikka, P., S. Nikkari, O. Ruuskanen, M. Leinonen, and J. Mertso-la. 1999. Pneumolysin PCR-based diagnosis of invasive pneumococ-cal infection in children. J. Clin. Microbiol. 37:633-637
93. Tomasz, A. 1984. Building and breaking of bonds in the cell wall of bacteria- the role for autolysin, p. 3-12. In C. Nombela (ed.), Microbial cell wall and autolysin. Elsvier Science Publishers, Amsterdam, The Netherlands.
94. Walker, J. A., R. L. Allen, P. Falmagne, M. K. Boulnois, G. J. 1987.
Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Strepto-coccus pneumoniae. Infect. Immun. 55:1184-9.
95. Williams J. R., J. H., M. V. Pahl, D. Kwong, J. Zhang, D. Hatake-yama, K. Ahmad, M. Naderi, M. Kim, N. Vaziri. 2003. Modulation of neutrophil complement receptor 3 expression by pneumococci. Clin.
Sci. 104:615-25.